Related Experiment Video
Updated: May 20, 2025
Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
Published on: May 26, 2023
Extracorporeal membrane oxygenation (ECMO) in pediatric congenital heart disease: a comprehensive review
Muhammad Shaheer Bin Faheem1, Hafiza Qurat Ul Ain2, Muhammad Haroon-Ul-Rasheed2
1Karachi Institute of Medical Sciences, KIMS - CMH Malir, Karachi, Pakistan. mshaheerfaheem@gmail.com.
Insights
Extracorporeal membrane oxygenation (ECMO) offers life support for pediatric congenital heart disease (CHD) patients. Advances improve outcomes, but cost and accessibility remain challenges for this critical treatment.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Surgery
- Critical Care Medicine
Background:
- Extracorporeal membrane oxygenation (ECMO) is vital for pediatric congenital heart disease (CHD).
- It supports patients with severe cardiac and pulmonary failure.
Purpose of the Study:
- To review the evolution and clinical applications of ECMO in pediatric CHD.
- To discuss outcomes, challenges, and recent advancements in ECMO therapy for CHD.
Main Methods:
- Review of historical development and clinical uses of ECMO.
- Analysis of outcomes, including complications and long-term effects.
- Examination of recent technological and pharmacological advancements.
Main Results:
- ECMO serves as a bridge to recovery, post-surgical stabilization, and heart transplantation.
- Improved cannulation techniques enhance outcomes, yet bleeding and neurologic issues persist.
- New anticoagulants (bivalirudin) and neuroprotective agents show promise.
Conclusions:
- Ongoing advancements in ECMO technology and patient care are improving efficacy and safety.
- High cost and limited accessibility hinder widespread ECMO use, particularly in resource-limited settings.
- Future research should focus on overcoming these barriers to ECMO accessibility.
Background:
Extracorporeal membrane oxygenation (ECMO), which provides life-saving assistance in severe cardiac and pulmonary failure cases, has emerged as an important technique in managing children with congenital heart disease (CHD).
Main Body:
In this review, we discuss the evolution of ECMO over the years, its clinical uses, and the results in pediatric CHD. ECMO has been utilized as a bridge to recovery, in stabilizing an individual after surgery, and as a bridge to heart transplantation. Cannulation procedures that are adjusted according to the anatomy of an individual have improved outcomes, although bleeding and neurologic concerns remain a matter of concern. In addition, long-term neurodevelopmental disorders and renal failure are also among the alarming outcomes. The use of newer anticoagulant drugs like bivalirudin, which lowers the risk of bleeding, and genomic testing for personalized treatment are examples of recent developments. Furthermore, neuroprotective techniques such as erythropoietin and dexmedetomidine can also enhance the neurocognitive outcomes. Finally, improvements in monitoring systems and pump technology contribute to increased ECMO efficacy and safety.
Conclusion:
Despite these developments, ECMO's expense and restricted accessibility remain major obstacles, especially in areas with low resources. In this review, the advancements in ECMO technology and care are highlighted, and it also emphasizes future research to address the current challenges.
Related Concept Videos
01:29Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:16Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
01:23Acute Respiratory Failure-IV